1
|
Baumgart DC and Carding SR: Inflammatory
bowel disease: cause and immunobiology. Lancet. 369:1627–1640.
2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Baumgart DC and Sandborn WJ: Inflammatory
bowel disease: clinical aspects and established and evolving
therapies. Lancet. 369:1641–1657. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Podolsky DK: Inflammatory bowel disease. N
Engl J Med. 347:417–429. 2002. View Article : Google Scholar
|
4
|
Xavier RJ and Podolsky DK: Unravelling the
pathogenesis of inflammatory bowel disease. Nature. 448:427–434.
2007. View Article : Google Scholar
|
5
|
Cho JH: The genetics and
immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol.
8:458–466. 2008. View
Article : Google Scholar
|
6
|
Van Limbergen J, Wilson DC and Satsangi J:
The genetics of Crohn’s disease. Annu Rev Genomics Hum Genet.
10:89–116. 2009.
|
7
|
Duerr RH, Taylor KD, Brant SR, et al: A
genome-wide association study identifies IL23R as an inflammatory
bowel disease gene. Science. 314:1461–1463. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Glas J, Konrad A, Schmechel S, et al: The
ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly
associated with susceptibility to Crohn’s disease in the German
population. Am J Gastroenterol. 103:682–691. 2008.PubMed/NCBI
|
9
|
Glas J, Seiderer J, Wetzke M, et al:
rs1004819 is the main disease-associated IL23R variant in German
Crohn’s disease patients: combined analysis of IL23R, CARD15, and
OCTN1/2 variants. PLoS One. 2:e8192007.PubMed/NCBI
|
10
|
Hampe J, Franke A, Rosenstiel P, et al: A
genome-wide association scan of nonsynonymous SNPs identifies a
susceptibility variant for Crohn disease in ATG16L1. Nat Genet.
39:207–211. 2007. View
Article : Google Scholar : PubMed/NCBI
|
11
|
Hugot JP, Chamaillard M, Zouali H, et al:
Association of NOD2 leucine-rich repeat variants with
susceptibility to Crohn’s disease. Nature. 411:599–603. 2001.
|
12
|
Ogura Y, Bonen DK, Inohara N, et al: A
frameshift mutation in NOD2 associated with susceptibility to
Crohn’s disease. Nature. 411:603–606. 2001.
|
13
|
Parkes M, Barrett JC, Prescott NJ, et al:
Sequence variants in the autophagy gene IRGM and multiple other
replicating loci contribute to Crohn’s disease susceptibility. Nat
Genet. 39:830–832. 2007.PubMed/NCBI
|
14
|
Rioux JD, Xavier RJ, Taylor KD, et al:
Genome-wide association study identifies new susceptibility loci
for Crohn disease and implicates autophagy in disease pathogenesis.
Nat Genet. 39:596–604. 2007. View
Article : Google Scholar : PubMed/NCBI
|
15
|
Ihle JN: The Stat family in cytokine
signaling. Curr Opin Cell Biol. 13:211–217. 2001. View Article : Google Scholar : PubMed/NCBI
|
16
|
Remmers EF, Plenge RM, Lee AT, et al:
STAT4 and the risk of rheumatoid arthritis and systemic lupus
erythematosus. N Engl J Med. 357:977–986. 2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Martinez A, Varade J, Marquez A, et al:
Association of the STAT4 gene with increased susceptibility for
some immune-mediated diseases. Arthritis Rheum. 58:2598–2602. 2008.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Diaz-Gallo LM, Palomino-Morales RJ,
Gomez-Garcia M, et al: STAT4 gene influences genetic predisposition
to ulcerative colitis but not Crohn’s disease in the Spanish
population: a replication study. Hum Immunol. 71:515–519.
2010.PubMed/NCBI
|
19
|
Glas J, Seiderer J, Nagy M, et al:
Evidence for STAT4 as a common autoimmune gene: rs7574865 is
associated with colonic Crohn’s disease and early disease onset.
PLoS One. 5:e103732010.PubMed/NCBI
|
20
|
Satsangi J, Silverberg MS, Vermeire S and
Colombel JF: The Montreal classification of inflammatory bowel
disease: controversies, consensus, and implications. Gut.
55:749–753. 2006. View Article : Google Scholar : PubMed/NCBI
|
21
|
Silverberg MS, Satsangi J, Ahmad T, et al:
Toward an integrated clinical, molecular and serological
classification of inflammatory bowel disease: report of a Working
Party of the 2005 Montreal World Congress of Gastroenterology. Can
J Gastroenterol. 19(Suppl A): S5–S36. 2005.
|
22
|
Li Z, Zhang Z, He Z, et al: A
partition-ligation-combination-subdivision EM algorithm for
haplotype inference with multiallelic markers: update of the SHEsis
(http://analysis.bio-x.cnuri).
Cell Res. 19:519–523. 2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Shi YY and He L: SHEsis, a powerful
software platform for analyses of linkage disequilibrium, haplotype
construction, and genetic association at polymorphism loci. Cell
Res. 15:97–98. 2005. View Article : Google Scholar : PubMed/NCBI
|
24
|
Korman BD, Kastner DL, Gregersen PK and
Remmers EF: STAT4: genetics, mechanisms, and implications for
autoimmunity. Curr Allergy Asthma Rep. 8:398–403. 2008. View Article : Google Scholar : PubMed/NCBI
|
25
|
Orozco G, Alizadeh BZ, Delgado-Vega AM, et
al: Association of STAT4 with rheumatoid arthritis: a replication
study in three European populations. Arthritis Rheum. 58:1974–1980.
2008. View Article : Google Scholar : PubMed/NCBI
|
26
|
Zervou MI, Goulielmos GN, Castro-Giner F,
Tosca AD and Krueger-Krasagakis S: STAT4 gene polymorphism is
associated with psoriasis in the genetically homogeneous population
of Crete, Greece. Hum Immunol. 70:738–741. 2009. View Article : Google Scholar : PubMed/NCBI
|
27
|
Moon CM, Cheon JH, Kim SW, et al:
Association of signal transducer and activator of transcription 4
genetic variants with extra-intestinal manifestations in
inflammatory bowel disease. Life Sci. 86:661–667. 2010. View Article : Google Scholar : PubMed/NCBI
|
28
|
Hellquist A, Sandling JK, Zucchelli M, et
al: Variation in STAT4 is associated with systemic lupus
erythematosus in a Finnish family cohort. Ann Rheum Dis.
69:883–886. 2010. View Article : Google Scholar : PubMed/NCBI
|
29
|
Luan H, Li P, Cao C, et al: A
single-nucleotide polymorphism of the STAT4 gene is associated with
systemic lupus erythematosus (SLE) in female Chinese population.
Rheumatol Int. 32:1251–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
30
|
Sigurdsson S, Nordmark G, Garnier S, et
al: A risk haplotype of STAT4 for systemic lupus erythematosus is
over-expressed, correlates with anti-dsDNA and shows additive
effects with two risk alleles of IRF5. Hum Mol Genet. 17:2868–2876.
2008. View Article : Google Scholar : PubMed/NCBI
|